MOLCURE https://validator.w3.org/feed/docs/rss2.html MOLCURE to Present at Kick-off Event for the National Cancer Center Tsuruoka Collaborative Research Center’s Third-Phase Project, October 13 国立がん研究センター・鶴岡連携研究拠点 第3期プロジェクト キックオフイベントに登壇, October 13 BioJapan 2026: MOLCURE to Speak at iPark Institute and Johnson & Johnson Session, October 9 BioJapan 2026でアイパークインスティチュート・Johnson & Johnson共催セッションに登壇, October 9 MOLCURE Joins Project Selected under JST’s AI to Redesign Scientific Exploration (ARiSE) Program as Co-Investigator, September 29 JST「AI for Science革新的研究推進事業（ARiSE）」採択課題に研究開発分担者として参画, September 29 BioJapan 2026: MOLCURE to Exhibit and Present, October 7-9 BioJapan 2026での出展・講演のお知らせ, October 7-9 Hitachi Social Innovation Forum 2026 JAPAN Special Seminar Featured MOLCURE, September 4 Hitachi Social Innovation Forum 2026 JAPAN 特別セミナーで講演, September 4 Home_EN Home_JP MOLCURE Launches Collaboration with Axcelead Drug Discovery Partners to Discover Peptide Drug Candidates Using MOLCURE’s AI-driven Platform, September 8 Axcelead Drug Discovery PartnersとAI創薬技術を活用したペプチド創薬で協業を開始, September 8 Innovation Tiger 2026: MOLCURE to Deliver a Finalist Pitch, September 15 「イノベーションタイガー2026」にMOLCUREがファイナリストとしてピッチ登壇, September 15 Speaking at Shonan iPark’s 8th VC Consortium Special Event, August 26 湘南アイパーク「第8回VCコンソーシアムスペシャルイベント」に登壇, August 26 MOLCURE at BIO 2026, June 22-25 BIO 2026にMOLCUREが参加, June 22-25 Speaking at Illumina Webinar, June 16 イルミナ社主催ウェビナーに登壇, June 16 Nikkei xTECH Features Interview with MOLCURE, May 27 日経xTECHにインタビュー記事が掲載, May 27 Hitachi to Develop Confidential AI Platform to Accelerate AI-Driven Drug Discovery via Open Innovation; Full-Scale Co-creation with MOLCURE Toward Service Launch, April 16 日立、オープンイノベーションによるAI創薬を加速する「秘匿AI基盤」を開発へ。サービス提供に向けてMOLCUREと協創本格化, April 16 MOLCURE Achieves Milestone in Joint AI Drug Discovery Research with Pharma Foods, May 1 株式会社ファーマフーズとのAI創薬に係る共同研究のマイルストーン達成のお知らせ, May 1 MOLCURE Signs Joint Research Agreement with Teijin Pharma to Develop Antibody Drugs Using AI-Driven Drug Discovery Platform Technology, January 9 帝人ファーマとAI創薬プラットフォーム技術を活用した抗体医薬品の創製に関する共同研究契約を締結, January 9 帝人ファーマとAI技術を活用した抗体医薬品創製に関する共同研究を完了し、継続プロジェクト契約を締結, September 18 MOLCURE and Teijin Pharma Complete First Phase of Joint Research and Expand Partnership, September 18 Team_JP Team_EN Speaking at the Juntendo University Lecture “The Frontline of AI Drug Discovery and the Future of the Ecosystem”, March 26 順天堂大学講演会「AI創薬の最前線とエコシステムの未来」に登壇, March 26 XTC JAPAN 2026: MOLCURE Won the Applied Intelligence Award, March 4 XTC JAPAN 2026でMOLCUREがApplied Intelligence Awardを受賞, March 4 XTC JAPAN 2026: CEO/CSO Tamaki to Deliver Finalist Pitch, March 3 XTC JAPAN 2026ファイナリストとしてCEO/CSO玉木が登壇, March 3 CEO/CSO Tamaki at The University of Osaka WPI PRIMe Symposium, February 6 CIO Ogawa to Speak at JBA Seminar, February 16 CIO小川が「JBA創薬モダリティ基盤研究会セミナー」に登壇, February 16 CEO/CSO玉木が大阪大学WPI PRIMe国際シンポジウムに登壇, February 6 MOLCURE and KM Biologics Enter into Research Agreement for AI-Powered Discovery of Next-Generation Biopharmaceuticals, January 28 ＫＭバイオロジクスとAI創薬プラットフォーム技術を活用した次世代医薬品の創製に関する契約を締結, January 28 MOLCURE and Teijin Pharma Sign New Agreement to Continue Joint Research Using MOLCURE’s AI Platform, January 7 帝人ファーマとのAI技術を活用した共同研究に関する新規継続契約締結のお知らせ, January 7 CEO/CSO Tamaki to Speak at the 469th CBI Society Seminar, December 9 CEO/CSO玉木が第469回CBI学会講演会に登壇, December 9